Results 101 to 110 of about 8,307 (217)

Biopsy-proven progressive multifocal leukoencephalopathy in a renal transplant patient

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2019
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease that affects immunocompromised hosts. Most often the disease is reported in association with leukemia, lymphoma, and AIDS.
Pramod Kumar Guru   +3 more
doaj   +1 more source

Case report: Progressive multifocal leukoencephalopathy co-occurring with neurosarcoidosis: early brain biopsy and appropriate therapy for PML resulted in a favorable prognosis

open access: yesFrontiers in Immunology
Progressive multifocal leukoencephalopathy (PML) is a rare central nervous system disease caused by JC virus (JCV) infection. Human immunodeficiency virus (HIV) infection is the greatest risk factor for PML.
Qiannan Wang   +8 more
doaj   +1 more source

Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis

open access: yesClinical Ophthalmology, 2012
Tina Rike Herold,1 Veronika Jakl,3 Anno Graser,4 Kirsten Eibl-Lindner1,21Department of Ophthalmology, 2Department of Ophthalmology, Campus Innenstadt, 3Department of Neurology, 4Department of Clinical Radiology, Campus Grosshadern, University of Munich ...
Herold TR   +3 more
doaj  

Progressive multifocal leukoencephalopathy: new concepts

open access: yesArquivos de Neuro-Psiquiatria, 2013
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the CNS caused by reactivation of JC virus (JCV) in a setting of cellular immunosuppression.
Marco A. Lima
doaj   +1 more source

Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta [PDF]

open access: yes, 2014
Background: De-escalating natalizumab (NTZ) to interferon beta 1b (IFN B 1B) is a possible treatment option in multiple sclerosis (MS) patients interrupting NTZ because of increased risk of progressive multifocal leukoencephalopathy (PML).
Calabrese, Pasquale   +6 more
core   +2 more sources

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

open access: yesPatient Related Outcome Measures, 2014
Raquel Planas, Roland Martin, Mireia Sospedra Neuroimmunology and MS Research, Department of Neurology, University of Zurich, Zurich, Switzerland Abstract: Natalizumab was the first monoclonal antibody to be approved for the treatment of relapsing ...
Planas R, Martin R, Sospedra M
doaj  

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Taiwanese Patient

open access: yesJournal of the Formosan Medical Association, 2007
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating brain disease caused by JC virus (JCV). Genomic analysis of viral isolates in these cases often shows prototype-like JCV and its variants, which is a virulent strain compared to ...
Yung-Yee Chang   +5 more
doaj   +1 more source

JC Virus Antibody and Viremia as Predictors of Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-1-Infected Individuals [PDF]

open access: yes, 2017
We examined whether prediagnostic John Cunningham virus (JCV) antibodies and viremia are predictors of progressive multifocal leukoencephalopathy (PML) in 83 PML cases and 240 human immunodeficiency virus (HIV) disease-matched controls.
Clifford, David B.   +10 more
core  

Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis

open access: yesАнналы клинической и экспериментальной неврологии, 2018
The review provides modern understanding of the pathogenesis of progressive multifocal leukoencephalopathy (PML), a severe and potentially fatal form of multiple-lesion disorder of the brain white matter.
Maria N. Zakharova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy